Jon Willie, M.D., Ph.D.
Associate Chair of Research, Department of Neurosurgery
Associate Professor, Department of Neurosurgery
Associate Professor, Department of Neurology
About
Jon Willie, MD, PhD, FAANS, is a board-certified stereotactic and functional neurosurgeon in UT Medicine’s Functional Neurosurgery Clinic. He specializes in functional, stereotactic and epilepsy surgery; movement disorder surgery; deep brain stimulation; laser interstitial thermal therapy (laser ablation); intrathecal therapy; hydrocephalus and intraventricular endoscopy; and treatment of Parkinson’s disease, dystonia, tremor, spasticity and encephaloceles. Additionally, Dr. Willie is an associate professor in the Dell Medical School Department of Neurosurgery at The University of Texas at Austin.
Dr. Willie earned his bachelor’s degree in biochemistry with honors from The University of Texas at Austin and both his medical degree and doctorate in biomedical sciences at The University of Texas Southwestern Medical Center. He completed a residency in neurological surgery at Barnes-Jewish Hospital through the Washington University School of Medicine and a fellowship in stereotactic, functional and epilepsy neurosurgery at Emory University School of Medicine.
Dr. Willie is a nationally recognized leader in functional neurosurgery. He previously served as Director of Stereotactic, Functional and Epilepsy Surgery at Washington University School of Medicine and leads the Laboratory for Behavioral Neuromodulation. His research, supported by the National Institutes of Health (NIH) and other organizations, explores neuromodulation for memory, mood and seizure disorders, including how brain stimulation can improve memory, reduce seizures and alleviate symptoms of conditions such as post-traumatic stress disorder (PTSD) and depression. He actively participates in clinical trials and has authored over 100 peer-reviewed publications and regularly lectures at national and international conferences. Please note: Dr. Willie will begin seeing patients on Nov. 10, 2025.